FLGT News and Press, Fulgent Genetics Inc. From 11/07/25

A look at the top 10 most actives in the United States BIO-key International Inc. (BKYI) rose 64.6% to $1.045 on volume of 460,286,784 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.9% to $3.7823 on volume of 408,669,986 shares Rubico Inc. (RUBI) rose 41.7% to $0.3188 on v...

2025-11-07 14:57:34 ET More on Fulgent Genetics Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript Fulgent Genetics, Inc. 2025 Q3 - Results - Earnings Call Presentation Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track ...

2025-11-07 14:56:17 ET Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST... Read the full article on Seeking Alpha For further details see: Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript

2025-11-07 07:06:48 ET More on Fulgent Genetics Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy) Fulgent Genetics Q3 2025 Earnings Preview Seeking Alpha’s Quant Rating on Fulgent Genetics Historical ...

Revenue of $84.1 million, growing 17% year-over-year Raising Full Year 2025 Revenue Guidance to $325.0 million Raising Full Year 2025 EPS Guidance to GAAP loss of approximately ($1.70) per share and Non-GAAP income of $0.30 per share GAAP gross profit of $35.5 million, or GAAP gross m...

1stdibs.com Inc. (DIBS) is expected to report $-0.13 for Q3 2025 Delek Logistics Partners L.P. representing Limited Partner Interests (DKL) is expected to report $1.11 for Q3 2025 Claritev Corp Cl A (New) (CTEV) is expected to report $-3.12 for Q3 2025 AirSculpt Technologies Inc. (AIR...

2025-11-06 10:37:00 ET More on Fulgent Genetics Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy) Seeking Alpha’s Quant Rating on Fulgent Genetics Historical earnings data for Fulgent Genetics Financi...

2025-11-02 08:07:14 ET The first full week of November delivers a broad and high-impact earnings lineup across semiconductors, cloud software, AI, consumer retail, healthcare, cannabis, energy, media, and crypto-linked names, offering one of the most diversified snapshots of corporate senti...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced preliminary clinical data as of September 25, 2025, the prelimina...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its third quarter 2025 financial results bef...